ConductScience.org, home

Trial · NCT07902011

CTEPH Differential Diagnosis Assisted by Enhanced Large Language Model Support

NCT07902011, Not applicable, Not yet recruiting, China-Japan Friendship Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. CTEPH Differential Diagnosis Assisted by Enhanced Large Language Model Support. Trials, record NCT07902011. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07902011

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
CTEPH Differential Diagnosis Assisted by Enhanced Large Language Model Support
NCT number
NCT07902011
Status
Not yet recruiting
Phases
Not applicable
Enrollment
60 participants, estimated
Lead sponsor
China-Japan Friendship Hospital
Conditions
Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Acute Pulmonary Embolism (PE), Pulmonary Artery Sarcoma
Interventions
Locked CTEPH-LLM Diagnostic Decision Support
First posted
2026-10-28
Last updated
2026-10-29

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryStage 4 CTEPH Identification SensitivityAt completion of Stage 4 for each case, within 14 days after the clinician's first formal case-reading session
The proportion of evaluable physician-case judgments for the 10 reference-standard CTEPH cases in which the physician's final Top-1 diagnosis after Stage 4 is CTEPH. The numerator is the number of correct CTEPH identifications and the denominator is the number of evaluable Stage 4 judgments for CTEPH cases. The between-group comparison will account for clustering by physician and case.
PrimaryStage 4 Three-Class Top-1 Diagnostic AccuracyDuring the two formal case-reading sessions, completed within 14 days after the first sessionThe proportion of evaluable Stage 4 physician-case judgments in which the clinician's Top-1 diagnosis matches the reference diagnosis among CTEPH, acute PE, and PAS.
SecondaryStage 4 Class-Specific Diagnostic PerformanceDuring the two formal case-reading sessions, completed within 14 days after the first session
For CTEPH, acute PE, and PAS separately, sensitivity, specificity, positive predictive value, and negative predictive value will be calculated from evaluable Stage 4 Top-1 diagnoses against the prespecified reference standard.
SecondaryDiagnostic Response TimeDuring the two formal case-reading sessions, completed within 14 days after the first session
Total response time across all cases and response time at each information stage will be recorded automatically by the study platform. Time will be summarized in seconds or minutes, using means with standard deviations or medians with interquartile ranges as appropriate.
SecondaryStage-Wise Diagnostic ChangeDuring the two formal case-reading sessions, completed within 14 days after the first session
Changes in the clinician's Top-1 diagnosis and recorded diagnostic probabilities from Stage 1 through Stage 4 will be summarized, including the proportion of judgments that change between consecutive stages and between Stage 1 and Stage 4.
SecondaryAI-Assisted Correction Rate When the AI Recommendation Is CorrectDuring the two formal case-reading sessions, completed within 14 days after the first session
Among LLM-assisted judgments in which the clinician's diagnosis before considering the stage-specific AI output is incorrect and the AI Top-1 diagnosis is correct, the proportion in which the clinician submits the correct diagnosis after receiving the AI output.
SecondaryAI-Related Over-Reliance Rate When the AI Recommendation Is IncorrectDuring the two formal case-reading sessions, completed within 14 days after the first session
Among LLM-assisted judgments in which the clinician's diagnosis before considering the stage-specific AI output is correct and the AI Top-1 diagnosis is incorrect, the proportion in which the clinician changes to the incorrect AI diagnosis after receiving the AI output.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07902011

GET https://conductscience.org/api/trials/v1/NCT07902011/registered